Latest Insider Transactions at Resmed Inc (RSMDF)
This section provides a real-time view of insider transactions for Resmed Inc (RSMDF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RESMED INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RESMED INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.44%
|
$502,500
$201.37 P/Share
|
|
Feb 03
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.11%
|
$303,348
$204.42 P/Share
|
|
Feb 01
2021
|
Rajwant Sodhi President, SaaS Business |
SELL
Open market or private sale
|
Direct |
1,500
-4.34%
|
$304,500
$203.76 P/Share
|
|
Feb 01
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-2.66%
|
$480,000
$200.18 P/Share
|
|
Jan 18
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,014
+1.7%
|
-
|
|
Jan 18
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
4,099
+19.71%
|
-
|
|
Jan 18
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,822
+1.75%
|
-
|
|
Jan 18
2021
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
1,913
+2.08%
|
-
|
|
Jan 18
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,548
+1.14%
|
-
|
|
Jan 18
2021
|
Rajwant Sodhi President, SaaS Business |
BUY
Grant, award, or other acquisition
|
Direct |
1,913
+5.24%
|
-
|
|
Jan 18
2021
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
865
+2.22%
|
-
|
|
Jan 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
938
-0.44%
|
$198,856
$212.86 P/Share
|
|
Jan 11
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.42%
|
$545,000
$218.7 P/Share
|
|
Jan 04
2021
|
Rajwant Sodhi President, SaaS Business |
SELL
Open market or private sale
|
Direct |
1,500
-4.39%
|
$319,500
$213.24 P/Share
|
|
Jan 04
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.11%
|
$316,731
$213.24 P/Share
|
|
Jan 04
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-2.65%
|
$506,400
$211.09 P/Share
|
|
Dec 15
2020
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
970
-0.45%
|
$200,790
$207.8 P/Share
|
|
Dec 10
2020
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.37%
|
$527,500
$211.06 P/Share
|
|
Dec 03
2020
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.1%
|
$309,296
$208.36 P/Share
|
|
Dec 01
2020
|
Rajwant Sodhi President, SaaS Business |
SELL
Open market or private sale
|
Direct |
1,500
-4.2%
|
$315,000
$210.46 P/Share
|
|
Dec 01
2020
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-2.58%
|
$504,000
$210.97 P/Share
|
|
Nov 27
2020
|
Jan De Witte Director |
SELL
Payment of exercise price or tax liability
|
Direct |
183
-4.24%
|
$38,796
$212.11 P/Share
|
|
Nov 27
2020
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-2.17%
|
$24,592
$212.11 P/Share
|
|
Nov 24
2020
|
Robert Andrew Douglas Special Advisor |
SELL
Bona fide gift
|
Indirect |
478
-0.22%
|
-
|
|
Nov 24
2020
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
955
-0.44%
|
$201,505
$211.0 P/Share
|
|
Nov 24
2020
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.52%
|
$1,055,000
$211.0 P/Share
|
|
Nov 23
2020
|
David Pendarvis Chief Administrative Officer |
SELL
Bona fide gift
|
Direct |
10,000
-6.89%
|
-
|
|
Nov 20
2020
|
David Pendarvis Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,176
+0.8%
|
$98,784
$84.98 P/Share
|
|
Nov 19
2020
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,187
+0.52%
|
-
|
|
Nov 19
2020
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,187
+28.94%
|
-
|
|
Nov 19
2020
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,187
+21.55%
|
-
|
|
Nov 19
2020
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,187
+18.17%
|
-
|
|
Nov 19
2020
|
Richard Sulpizio Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,187
+8.45%
|
-
|
|
Nov 19
2020
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
594
+7.84%
|
-
|
|
Nov 19
2020
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,187
+4.95%
|
-
|
|
Nov 17
2020
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
15,547
-14.31%
|
$3,327,058
$214.74 P/Share
|
|
Nov 17
2020
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
26,246
+19.45%
|
$5,616,644
$214.74 P/Share
|
|
Nov 17
2020
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
34,958
-42.61%
|
$7,481,012
$214.74 P/Share
|
|
Nov 17
2020
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
59,057
+41.86%
|
$12,638,198
$214.74 P/Share
|
|
Nov 17
2020
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,445
-7.95%
|
$2,663,230
$214.74 P/Share
|
|
Nov 17
2020
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,310
+12.48%
|
$4,774,340
$214.74 P/Share
|
|
Nov 17
2020
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,776
-11.09%
|
$10,652,064
$214.74 P/Share
|
|
Nov 17
2020
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,238
+16.58%
|
$19,096,932
$214.74 P/Share
|
|
Nov 17
2020
|
Rajwant Sodhi President, SaaS Business |
SELL
Payment of exercise price or tax liability
|
Direct |
10,249
-22.32%
|
$2,193,286
$214.74 P/Share
|
|
Nov 17
2020
|
Rajwant Sodhi President, SaaS Business |
BUY
Grant, award, or other acquisition
|
Direct |
18,373
+28.58%
|
$3,931,822
$214.74 P/Share
|
|
Nov 17
2020
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,246
+19.18%
|
$5,616,644
$214.74 P/Share
|
|
Nov 17
2020
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,813
+24.1%
|
$2,527,982
$214.74 P/Share
|
|
Nov 11
2020
|
James Hollingshead President, Sleep Business |
SELL
Payment of exercise price or tax liability
|
Direct |
5,225
-2.03%
|
$1,107,700
$212.11 P/Share
|
|
Nov 11
2020
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,717
-6.95%
|
$364,004
$212.11 P/Share
|
|
Nov 11
2020
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
579
-0.25%
|
$122,748
$212.11 P/Share
|